195 related articles for article (PubMed ID: 16786535)
1. Methylthioadenosine reverses brain autoimmune disease.
Moreno B; Hevia H; Santamaria M; Sepulcre J; Muñoz J; García-Trevijano ER; Berasain C; Corrales FJ; Avila MA; Villoslada P
Ann Neurol; 2006 Sep; 60(3):323-34. PubMed ID: 16786535
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
Zhang Z; Zhang ZY; Wu Y; Schluesener HJ
Neuroscience; 2012 Sep; 221():140-50. PubMed ID: 22800566
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE).
Penkowa M; Hidalgo J
Exp Neurol; 2001 Jul; 170(1):1-14. PubMed ID: 11421579
[TBL] [Abstract][Full Text] [Related]
4. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
[TBL] [Abstract][Full Text] [Related]
5. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
6. The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis.
Rajan AJ; Klein JD; Brosnan CF
J Immunol; 1998 Jun; 160(12):5955-62. PubMed ID: 9637509
[TBL] [Abstract][Full Text] [Related]
7. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin.
Paintlia AS; Paintlia MK; Singh AK; Stanislaus R; Gilg AG; Barbosa E; Singh I
J Neurosci Res; 2004 Jul; 77(1):63-81. PubMed ID: 15197739
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kappaB inactivation.
Yun KJ; Koh DJ; Kim SH; Park SJ; Ryu JH; Kim DG; Lee JY; Lee KT
J Agric Food Chem; 2008 Nov; 56(21):10265-72. PubMed ID: 18841975
[TBL] [Abstract][Full Text] [Related]
9. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y; Mei Y; Feng D; Xu L
J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
11. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
[TBL] [Abstract][Full Text] [Related]
12. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis.
Einstein O; Grigoriadis N; Mizrachi-Kol R; Reinhartz E; Polyzoidou E; Lavon I; Milonas I; Karussis D; Abramsky O; Ben-Hur T
Exp Neurol; 2006 Apr; 198(2):275-84. PubMed ID: 16472805
[TBL] [Abstract][Full Text] [Related]
13. Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms.
Dutra RC; de Souza PR; Bento AF; Marcon R; Bicca MA; Pianowski LF; Calixto JB
Biochem Pharmacol; 2012 Feb; 83(4):531-42. PubMed ID: 22155310
[TBL] [Abstract][Full Text] [Related]
14. RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis.
DeVry CG; Valdez M; Gao L; Wang J; Kotsch K; Volk HD; Bechmann I; Buelow R; Iyer S
J Neuroimmunol; 2004 Jul; 152(1-2):33-43. PubMed ID: 15223235
[TBL] [Abstract][Full Text] [Related]
15. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
16. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Palaszynski KM; Liu H; Loo KK; Voskuhl RR
J Neuroimmunol; 2004 Apr; 149(1-2):84-9. PubMed ID: 15020068
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
Kanwar JR; Kanwar RK; Krissansen GW
Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.
Liedtke W; Cannella B; Mazzaccaro RJ; Clements JM; Miller KM; Wucherpfennig KW; Gearing AJ; Raine CS
Ann Neurol; 1998 Jul; 44(1):35-46. PubMed ID: 9667591
[TBL] [Abstract][Full Text] [Related]
20. Effect of mineral trioxide aggregate on rat clonal dental pulp cells: expression of cyclooxygenase-2 mRNA and inflammation-related protein via nuclear factor kappa B signaling system.
Minamikawa H; Deyama Y; Nakamura K; Yoshimura Y; Kaga M; Suzuki K; Yawaka Y
J Endod; 2009 Jun; 35(6):843-6. PubMed ID: 19482183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
